InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
Recruiting now
Conditions studied: Gastric Cancer
In brief
Multicentric, exploratory, non-pharmacologic, retrospective/prospective, translational study aiming to identify the molecular, cellular and psychological-sociological variables predictive of response to chemotherapy in gastric cancer patients.
Key facts
- Study ID
- NCT04842916
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- People needed
- 250
- Starts
- 2020-09-22
- Expected to finish
- 2027-05-22
- Last updated by the study team
- 2024-11-21
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with diagnosis of histologically confirmed, potentially resectable adenocarcinoma of the stomach (GC) or the gastric-esophageal junction (GEJ) treated with the standard regimens (5-Fluoro-Uracil or Capecitabine + Oxaliplatin +/- Docetaxel)
- Participant is willing and able to give informed consent for participation in the study (prospective and retrospective cohort) or Substitutive Informed Consent Declaration Form will be subscribed by the PI for patients that are not reachable
- Male or Female, aged >18 years
- Availability of tissue samples and clinico-pathological data for retrospective cohort
You may not qualify if…
- Age < 18 years
- Early Gastric Cancer and T2 (if N0)
- Linitis plastica
- Positive peritoneal cytology or peritoneal involvement
- Distant metastases
- Patient refusal to participate
- Patient refusal to the use of their own samples for research
- Patient withdrawing from treatment plan whilst under therapy due to patient co-morbidities or failure to comply with clinical counselling
- Patients with underlying pathologies rendering sampling of biological material either as endangering patient's clinical status or as unusable
- Patients with mental illness hindering the capacity to provide precise information in questionnaires or successfully comply with caregiver's recommendations
Where it is running
- IRST IRCCS UO Oncologia — Meldola, Italy (enrolling)
- Centre Hospitalier Regional et Universitaire (CHRU) — Brest, France
- INSERM, Faculty of Medicine (UMR1078) — Brest, France
- 1st Department of Propaedeutic Surgery, National & Kapodistrian University of Athens (NKUA) — Athens, Greece
- AUSL Romagna, UO Oncologia — Ravenna, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.